Enjoy complimentary customisation on priority with our Enterprise License!
The empty capsules market share is estimated to increase by USD 1.10 billion from 2021 to 2026, increasing at an accelerating CAGR of 7.3%.
This market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers the market segmentation by type (gelatin, capsules, and non-gelatin capsules) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The market report also offers information on several market vendors, including ACG, Bright Pharma Caps Inc., Ajix Inc., Healthcaps India Ltd., Lonza Group Ltd., Mitsubishi Chemical Holdings Corp., Nectar Lifesciences Ltd., Qingdao Yiqing Biotechnology Co. Ltd., Roxlor LLC, Shanxi Guangsheng Medicinal Capsule Co. Ltd., Shanxi JC Biological Technology Co. Ltd., Snail Pharma Industry Co. Ltd., Suheung Co. Ltd., and Sunil Healthcare Ltd. among others. One of the key highlights of this report is the post-COVID-19 impact analysis on the market, which will help companies evaluate their business approaches for the future.
Get the Empty Capsules Market Size Forecast by Downloading the Report Sample
The increasing applications in the pharmaceutical industry are notably driving the market growth, although factors such as the risk of counterfeiting in the pharmaceutical industry may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the empty capsules industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Empty Capsules Market Driver
Key Empty Capsules Market Trend
Key Empty Capsules Market Challenge
This market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global empty capsules market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the market encompasses successful business strategies deployed by the key vendors. The market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.
The market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the empty capsules market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Get a glance at the market share of various regions by Requesting a PDF sample now!
37% of the market's growth will originate from North America during the forecast period. The US is the key market for empty capsules in North America. Market growth in this region will be faster than the growth of the market in the Rest of the World (ROW).
The demand for US FDA-approved generic medicines will facilitate the market's growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID-19 Impact and Recovery Analysis
The outbreak of COVID-19 adversely impacted the regional pharmaceutical industry, primarily during the first half of 2020. However, the significant growth in the demand for generic and branded medicines, which are effective in curing lung congestion and fever, led pharmaceutical retailers to look for solutions to continue the supply of such medicines to the public. The vendors in the regional market have increased their investments in enhancing their distribution networks and are expanding their partnerships to strengthen their position in the market.
To gain insights on the market contribution of various segments Request a PDF sample
The market share growth in the gelatin capsules segment will be significant during the forecast period. Gelatin capsules offer convenient packaging that ensures reliable dosing, portability, and high consumer compliance. They are soft, which helps in the easy breakdown of the film and absorption of the drugs without any side effects. These gelatin capsules are widely used in medications and dietary supplements. Thus, the gelatin capsule segment is anticipated to witness growth in the global market during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the market size and actionable market insights on the post-COVID-19 impact on each segment.
Empty Capsules Market Scope |
|
Report Coverage |
Details |
Page number |
126 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.3% |
Market growth 2022-2026 |
$1.10 billion |
Market structure |
Fragmented |
YoY growth (%) |
6.7 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
ACG, Bright Pharma Caps Inc., Ajix Inc., Healthcaps India Ltd., Lonza Group Ltd., Mitsubishi Chemical Holdings Corp., Nectar Lifesciences Ltd., Qingdao Yiqing Biotechnology Co. Ltd., Roxlor LLC, Shanxi Guangsheng Medicinal Capsule Co. Ltd., Shanxi JC Biological Technology Co. Ltd., Snail Pharma Industry Co. Ltd., Suheung Co. Ltd., and Sunil Healthcare Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.